We are live on
!
Find out more
TC
TFS Capital Portfolio holdings
AUM
$255M
1-Year Est. Return
32.31%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.27B
AUM Growth
-$242M
(-16%)
Cap. Flow
-$285M
Cap. Flow
% of AUM
-22.45%
Top 10 Holdings %
Top 10 Hldgs %
6.3%
Holding
1,671
New
346
Increased
361
Reduced
380
Closed
578
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prothena Corp
PRTA
|
+$7.16M |
| 2 |
Diodes
DIOD
|
+$5.72M |
| 3 |
Insight Enterprises
NSIT
|
+$5.71M |
| 4 |
TECD
Tech Data Corp
TECD
|
+$5.28M |
| 5 |
CPWR
COMPUWARE CORP
CPWR
|
+$5.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RFMD
RF MICRO DEVICES INC
RFMD
|
+$7.01M |
| 2 |
Gentherm
THRM
|
+$6.87M |
| 3 |
ZLC
ZALE CORPORATION
ZLC
|
+$6.08M |
| 4 |
BERY
Berry Global Group, Inc.
BERY
|
+$5.96M |
| 5 |
Take-Two Interactive
TTWO
|
+$5.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.59% |
| 2 | Technology | 14.48% |
| 3 | Industrials | 10.28% |
| 4 | Financials | 9.62% |
| 5 | Consumer Discretionary | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZIXI
701
DELISTED
Zix Corporation
ZIXI
| $432K | 0.03% |
+126,325
| New | +$444K |
|
|
ZAGG
702
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $431K | 0.03% |
79,461
+53,831
| +210% | +$248K |
|
703
Corcept Therapeutics
CORT
$10.2B
| $426K | 0.03% |
152,271
-350,718
| -70% | -$1.04M |
|
|
CVGW
704
DELISTED
Calavo Growers
CVGW
| $426K | 0.03% |
+12,598
| New | +$412K |
|
705
Graham Corp
GHM
$1.22B
| $426K | 0.03% |
+12,242
| New | +$378K |
|
|
CXE
706
DELISTED
MFS High Income Municipal Trust
CXE
| $425K | 0.03% |
+88,797
| New | +$428K |
|
707
Papa John's
PZZA
$999M
| $424K | 0.03% |
10,013
-86,082
| -90% | -$3.83M |
|
|
BLT
708
DELISTED
BLOUNT INTERNATIONAL (NEW)
BLT
| $424K | 0.03% |
30,016
-31,782
| -51% | -$386K |
|
|
FPRX
709
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $420K | 0.03% |
27,005
+14,698
| +119% | +$211K |
|
|
IMPV
710
DELISTED
Imperva, Inc.
IMPV
| $420K | 0.03% |
16,052
-32,765
| -67% | -$846K |
|
711
BioCryst Pharmaceuticals
BCRX
$2.37B
| $419K | 0.03% |
+32,868
| New | +$320K |
|
|
MSD
712
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
| $417K | 0.03% |
41,018
+4,315
| +12% | +$43.8K |
|
|
ARDC
713
Are Dynamic Credit Allocation Fund
ARDC
$297M
| $414K | 0.03% |
22,739
-20,216
| -47% | -$368K |
|
714
Compass Diversified
CODI
$755M
| $414K | 0.03% |
22,801
+1,479
| +7% | +$26.4K |
|
|
X
715
DELISTED
US Steel
X
| $413K | 0.03% |
+15,855
| New | +$405K |
|
|
MODV
716
DELISTED
ModivCare
MODV
| $412K | 0.03% |
11,270
-92,800
| -89% | -$3.66M |
|
|
SAND
717
DELISTED
Sandstorm Gold
SAND
| $411K | 0.03% |
59,414
-34,328
| -37% | -$199K |
|
|
CCRN
718
DELISTED
Cross Country Healthcare
CCRN
| $410K | 0.03% |
62,934
+19,927
| +46% | +$132K |
|
|
FARM
719
DELISTED
Farmer Brothers
FARM
| $409K | 0.03% |
18,928
-21,829
| -54% | -$438K |
|
|
VASC
720
DELISTED
Vascular Solutions Inc
VASC
| $409K | 0.03% |
18,435
+8,059
| +78% | +$176K |
|
721
Travelzoo
TZOO
$103M
| $406K | 0.03% |
+21,001
| New | +$401K |
|
|
RIOM
722
DELISTED
RIO ALTO MNG LTD NEW COM SHS (CANADA)
RIOM
| $406K | 0.03% |
175,751
+23,971
| +16% | +$47.1K |
|
723
USA Compression Partners
USAC
$3.82B
| $404K | 0.03% |
15,735
+6,369
| +68% | +$166K |
|
724
Insmed
INSM
$23.2B
| $403K | 0.03% |
+20,193
| New | +$299K |
|
725
Commercial Metals
CMC
$7.63B
| $401K | 0.03% |
+23,173
| New | +$430K |
|
Similar funds
KC
IPC
ECPI
FRM
WFG
IFB
KL
RP
TFS Capital's Q2 2014 Portfolio in Review
As of Q2 2014, TFS Capital held 1,671 positions worth $1.27B, down 16% from $1.51B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
TFS Capital withdrew a net $285M in Q2 2014, closing 578 positions and reducing 380 holdings. Its most notable exit was ZALE CORPORATION, an estimated $6.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 12% a quarter earlier, followed by Technology and Industrials.
Against the trend, TFS Capital opened a new position in Tech Data Corp worth $5.32M.
- TFS Capital's largest Q2 2014 buy was Tech Data Corp: 85,151 shares worth $5.32M.
- TFS Capital added most to Prothena Corp in Q2 2014, an estimated $7.16M increase.
- TFS Capital's biggest Q2 2014 reduction was RF MICRO DEVICES INC, cutting an estimated $7.01M.
- TFS Capital fully exited ZALE CORPORATION in Q2 2014, selling an estimated $6.08M.
- TFS Capital's ten largest holdings make up 6.3% of its $1.27B portfolio in Q2 2014.
- TFS Capital opened 346 new positions and closed 578 in Q2 2014.
- TFS Capital's portfolio value fell 16% quarter-over-quarter to $1.27B.
Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.